| 08:30 - 10:30 | 331 | Multidrug-resistant tuberculosis and novel influenza: back to the future - "Lessons learnt from two respiratory emergencies" | Symposium |
| 08:30 - 10:30 | 332 | Pulmonary vascular involvement in COPD | Symposium |
| 08:30 - 10:30 | 333 | Pulmonary involvement in disorders of the gastrointestinal system | Symposium |
| 08:30 - 10:30 | 334 | Advances on breath monitoring of inflammatory airway disease | Hot topics |
| 08:30 - 10:30 | 335 | Reduced endogenous anti-inflammatory mediators as a new mechanism of airway disease | Symposium |
| 08:30 - 10:30 | 336 | Lung cancer progress after first-line therapy: which treatment makes sense and which does not? | Symposium |
| 08:30 - 10:30 | 337 | Diagnosis and management of hypoventilation syndromes in children | Symposium |
| 08:30 - 10:30 | 338 | Clinical issues in idiopathic pulmonary fibrosis | Oral Presentation |
| 08:30 - 10:30 | 339 | Sepsis and multiorgan failure | Oral Presentation |
| 08:30 - 10:30 | 340 | The impact of genes and environment on obstructive airway diseases | Oral Presentation |
| 08:30 - 10:30 | 341 | What's new in pulmonary rehabilitation and chronic care in 2010 | Oral Presentation |
| 08:30 - 10:30 | 342 | Risk assessment and prevention of complications in thoracic surgery | Oral Presentation |
| 08:30 - 10:30 | 343 | News from noninvasive ventilation | Oral Presentation |
| 08:30 - 10:30 | 344 | Spotlight on lung function | Oral Presentation |
| 08:30 - 10:30 | 345 | Clinical diagnosis and management of malignant pleural effusions | E-Communication Session |
| 08:30 - 10:30 | 346 | Models of airways disease | E-Communication Session |
| 08:30 - 10:30 | 347 | New insights into reactive oxygen species | E-Communication Session |
| 08:30 - 10:30 | 348 | Tuberculosis in children | E-Communication Session |
| 08:30 - 10:30 | 349 | Questionnaires use and psychological aspects in asthma | E-Communication Session |
| 08:30 - 10:30 | 350 | Paediatric respiratory epidemiology: early origins of childhood asthma | E-Communication Session |
| 10:45 - 12:45 | 351 | Imaging Grand Round: an interactive session | Grand round |
| 10:45 - 12:45 | 352 | Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension | Hot topics |
| 10:45 - 12:45 | 353 | Climate change and respiratory health | Symposium |
| 10:45 - 12:45 | 354 | Challenges in sleep medicine: ventilatory failure during sleep | Symposium |
| 10:45 - 12:45 | 355 | A new understanding of childhood wheeze phenotypes | Symposium |
| 10:45 - 12:45 | 356 | Fat tissue and pulmonary diseases: a new link? | Hot topics |
| 10:45 - 12:45 | 357 | Alternatives to classic anatomical resection for lung tumour | Symposium |
| 10:45 - 12:45 | 358 | COPD exacerbation | Oral Presentation |
| 10:45 - 12:45 | 359 | Peripheral and respiratory muscles oxygen transport during exercise | Oral Presentation |
| 10:45 - 12:45 | 360 | Biomarkers of asthma and COPD: recent advances | Oral Presentation |
| 10:45 - 12:45 | 361 | Aetiology and outcomes of infective exacerbations of COPD | Oral Presentation |
| 10:45 - 12:45 | 362 | Basic mechanisms in malignant pleural disease biology | Oral Presentation |
| 10:45 - 12:45 | 363 | Tuberculosis and HIV coinfection | Oral Presentation |
| 10:45 - 12:45 | 364 | New or old physiological parameters in chronic airway disorders? | Oral Presentation |
| 10:45 - 12:45 | 365 | Pulmonary venous thromboembolic disease | E-Communication Session |
| 10:45 - 12:45 | 366 | Cystic fibrosis: lung disease and much more | E-Communication Session |
| 10:45 - 12:45 | 367 | From the acute to the chronic patient: how do we use noninvasive ventilation? | E-Communication Session |
| 10:45 - 12:45 | 368 | Lung function from infancy to adulthood | E-Communication Session |
| 10:45 - 12:45 | 369 | Asthma: clinical aspects and treatment | E-Communication Session |
| 10:45 - 12:45 | 370 | Quality measurement and improvement in lung function | E-Communication Session |
| 12:50 - 14:40 | 371 | Treatment options for asthma | Thematic Poster Session |
| 12:50 - 14:40 | 372 | COPD: management | Thematic Poster Session |
| 12:50 - 14:40 | 373 | COPD: diagnosis | Thematic Poster Session |
| 12:50 - 14:40 | 374 | Pulmonary rehabilitation: understanding and developing the intervention | Thematic Poster Session |
| 12:50 - 14:40 | 375 | Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise | Thematic Poster Session |
| 12:50 - 14:40 | 376 | The psychological impact and educational issues of chronic lung disease: could we do more? | Thematic Poster Session |
| 12:50 - 14:40 | 377 | Exacerbations and COPD and rehabilitation | Thematic Poster Session |
| 12:50 - 14:40 | 378 | Infection, inflammation and destruction | Thematic Poster Session |
| 12:50 - 14:40 | 379 | New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy | Thematic Poster Session |
| 12:50 - 14:40 | 380 | Airway patency: the role of interventional bronchoscopy | Thematic Poster Session |
| 12:50 - 14:40 | 381 | Pathogenesis of diffuse parenchymal lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 382 | Clinical aspects in pulmonary fibrosis | Thematic Poster Session |
| 12:50 - 14:40 | 383 | Experimental approaches in pulmonary fibrosis | Thematic Poster Session |
| 12:50 - 14:40 | 384 | From diagnosis to disease management in primary care | Thematic Poster Session |
| 12:50 - 14:40 | 385 | Pulmonary infections and sepsis | Thematic Poster Session |
| 12:50 - 14:40 | 386 | Noninvasive ventilation: technical, logistical and organisational aspects | Thematic Poster Session |
| 12:50 - 14:40 | 387 | Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 388 | Asthma: basic science and clinical studies | Thematic Poster Session |
| 12:50 - 14:40 | 389 | Novel mechanisms in COPD | Thematic Poster Session |
| 12:50 - 14:40 | 390 | Macrophages: cell biology and disease-specific characteristics | Thematic Poster Session |
| 12:50 - 14:40 | 391 | Proteases and the matrix | Thematic Poster Session |
| 12:50 - 14:40 | 392 | Exercise in respiratory diseases and oxygen therapy | Thematic Poster Session |
| 12:50 - 14:40 | 393 | Sleep apnoea: insights from animal models and diagnostic tools | Thematic Poster Session |
| 12:50 - 14:40 | 394 | Clinical aspects of sleep apnoea | Thematic Poster Session |
| 12:50 - 14:40 | 395 | The upper airway and oral appliances | Thematic Poster Session |
| 12:50 - 14:40 | 396 | Lung morbidity on exposure to various agents | Thematic Poster Session |
| 12:50 - 14:40 | 397 | Pulmonary vascular diseases | Thematic Poster Session |
| 12:50 - 14:40 | 398 | Pulmonary embolism | Thematic Poster Session |
| 12:50 - 14:40 | 399 | Pulmonary venous thromboembolic disease and other pulmonary vascular disorders | Thematic Poster Session |
| 12:50 - 14:40 | 400 | Drug delivery and pharmacokinetics II | Thematic Poster Session |
| 12:50 - 14:40 | 401 | Management of airway disease | Thematic Poster Session |
| 12:50 - 14:40 | 402 | Pharmacological modulation of biomarkers and management | Thematic Poster Session |
| 12:50 - 14:40 | 403 | Innovations in the assessment of airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 404 | From rare towards common lung diseases: diagnostic and monitoring challenges | Thematic Poster Session |
| 12:50 - 14:40 | 405 | Biomarkers and Diagnosis of asthma and allergic respiratory diseases | Thematic Poster Session |
| 12:50 - 14:40 | 406 | Clinical aspects and treatment of asthma and allergic respiratory diseases | Thematic Poster Session |
| 12:50 - 14:40 | 407 | Various aspects of respiratory epidemiology | Thematic Poster Session |
| 12:50 - 14:40 | 408 | Occupational and environmental exposures and respiratory disease | Thematic Poster Session |
| 12:50 - 14:40 | 409 | Smoking related disorders | Thematic Poster Session |
| 12:50 - 14:40 | 410 | Advances in lung function from infancy to adolescence | Thematic Poster Session |
| 12:50 - 14:40 | 411 | Risk factors for allergic diseases in children | Thematic Poster Session |
| 12:50 - 14:40 | 412 | Quality of life, asthma control and monitoring childhood asthma | Thematic Poster Session |
| 12:50 - 14:40 | 413 | New aspects of cystic fibrosis | Thematic Poster Session |
| 12:50 - 14:40 | 414 | Paediatric epidemiology: asthma and associated factors | Thematic Poster Session |
| 12:50 - 14:40 | 415 | Infections and pleural problems | Thematic Poster Session |
| 12:50 - 14:40 | 416 | New clinical and experimental insights in lung transplantation | Thematic Poster Session |
| 12:50 - 14:40 | 417 | Exercise training: new groups, new methods and outcomes | Thematic Poster Session |
| 12:50 - 14:40 | 418 | Respiratory muscles and breathing: assessment and training | Thematic Poster Session |
| 12:50 - 14:40 | 419 | The nursing challenges and strategies when caring for patients with chronic lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 420 | Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients | Thematic Poster Session |
| 12:50 - 14:40 | 421 | The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools | Thematic Poster Session |
| 12:50 - 14:40 | 422 | Tuberculosis drug resistance | Thematic Poster Session |
| 12:50 - 14:40 | 423 | What is new in the diagnosis of tuberculosis? | Thematic Poster Session |
| 12:50 - 14:40 | 424 | Scientific advances in tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 425 | Epidemiology of lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 426 | Treatment of lung cancer | Thematic Poster Session |
| 13:00 - 14:30 | 427 | Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema" | Symposium |
| 13:00 - 14:15 | 428 | "ERS/Lancet" Asthma | Symposium |
| 13:00 - 14:15 | 429 | Ex vivo graft evaluation and reconditionning in human lung transplantation | Symposium |
| 13:00 - 14:15 | 430 | GOLD Update | Symposium |
| 13:00 - 14:15 | 431 | Physiological plasters and visiology: the visionary future for lung function? | Symposium |
| 13:00 - 14:00 | 433 | Emerging drugs in COPD | Meet the Professor |
| 13:00 - 14:00 | 434 | Ventilator-associated pneumonia | Meet the Professor |
| 13:00 - 14:00 | 435 | Telemonitoring of COPD patients at home | Meet the Professor |
| 13:00 - 14:00 | 436 | Mast cells and eosinophils: the two key effector cells in allergic inflammation | Meet the Professor |
| 13:00 - 14:00 | 437 | Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis | Meet the Professor |
| 13:15 - 14:15 | 441 | Practical Workshop: "NIV for Acute Respiratory Failure: where are we?" | Practical Workshop |
| 14:45 - 16:45 | 443 | Paediatric Grand Round: an interactive session | Grand round |
| 14:45 - 16:45 | 444 | Integrated care for chronic respiratory disease | Symposium |
| 14:45 - 16:45 | 445 | Novel molecular targets for inflammatory and infectious lung diseases | Symposium |
| 14:45 - 16:45 | 446 | Asthma and sports | Symposium |
| 14:45 - 16:45 | 447 | Donation after Cardiac Death (DCD) donors for lung transplantation | Hot topics |
| 14:45 - 16:45 | 448 | Mesothelioma and engineered nanotubes: cause for concern? | Hot topics |
| 14:45 - 16:45 | 449 | Mucous clearance and treatment modalities in respiratory physiotherapy | Oral Presentation |
| 14:45 - 16:45 | 450 | Smoking related disorders and smoking cessation | Oral Presentation |
| 14:45 - 16:45 | 451 | Pre-clinical models of airways disease | Oral Presentation |
| 14:45 - 16:45 | 452 | Airways mechanics in different applications | Oral Presentation |
| 14:45 - 16:45 | 453 | New insights in the pathology of lung cancer | Oral Presentation |
| 14:45 - 16:45 | 454 | Tuberculosis: from bench to bedside | Oral Presentation |
| 14:45 - 16:45 | 455 | Does cost-effectiveness go together with best quality of treatment? New drivers in medicine | Oral Presentation |
| 14:45 - 16:45 | 456 | Treatment and risk factors in lower respiratory tract infections | E-Communication Session |
| 14:45 - 16:45 | 457 | COPD: cardiovascular comorbidities | E-Communication Session |
| 14:45 - 16:45 | 458 | Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease | E-Communication Session |
| 14:45 - 16:45 | 459 | New insights in the epidemiology of asthma | E-Communication Session |
| 14:45 - 16:45 | 460 | Obesity: positive effects of bariatric surgery and exercise | E-Communication Session |
| 14:45 - 16:45 | 461 | State of the art imaging | E-Communication Session |
| 17:15 - 19:15 | 464 | Idiopathic pulmonary fibrosis: present understandings and future directions | Evening Symposium |
| 17:15 - 19:15 | 465 | Debugging COPD: the role of long-term antimicrobials in disease management | Evening Symposium |